A single combined measure of hsCRP, LDL-C, and Lp(a) can predict incident cardiovascular events across a 30-year period, and has potential for extending strategies for primary prevention of atherosclerotic events.
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
